Global Biopreservation Market to Reach USD 16.61 Billion by 2030, Fueled by Rising Funding Assistance in Healthcare
August 07, 2023 04:38 ET
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Biopreservation Market Size, Share & Trends Analysis Report By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine,...
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics Research Report 2023
July 20, 2023 04:53 ET
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics" report has been added to ResearchAndMarkets.com's offering. The...
Global Synthetic Biology Market Estimated to Hit $77.5 Billion by 2030: Synergy of AI and Synthetic Biology Creates Lucrative Growth Prospects
July 10, 2023 07:18 ET
|
Research and Markets
Dublin, July 10, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Synthetic...
eureKARE seeks disruptive synthetic biology solutions to tackle environmental and sustainability challenges
July 03, 2023 08:37 ET
|
EUREKARE
The 2nd edition of the eurekAWARDS is launched! Luxembourg, Belgium, Monaco, and Paris, France – 3 July 2023: eureKARE, a pioneering company focused on financing and building next generation...
Telesis Bio to Present at Jefferies Healthcare Conference 2023
June 08, 2023 09:05 ET
|
Telesis Bio
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder...
Synlogic Reminds Stockholders of 2023 Annual General Meeting Details
June 08, 2023 06:45 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., June 08, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today reminded stockholders that it will...
Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
May 24, 2023 06:35 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., May 24, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced its planned presentations at...
Telesis Bio to Present at SynBioBeta 2023
May 23, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...
Synlogic to Present at the Jefferies Global Healthcare Conference
May 23, 2023 06:50 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B....
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
May 22, 2023 12:00 ET
|
Telesis Bio
SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...